$MNKD Company News Skullcandy gains on upgrade
Post# of 94145
Posted On: 10/05/2014 12:47:35 PM
$MNKD Company News
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
MannKind Receives $150 Million Upfront Payment from Sanofi - Analyst Blog 5:10 p.m. Oct. 3, 2014 - Zacks.com
MannKind Reality Check 10:23 a.m. Oct. 2, 2014 - Seeking Alpha
Why MannKind Stock (MNKD) Is a Screaming Buy 10:16 a.m. Oct. 2, 2014 - InvestorPlace.com
With Ebola Looming, When Will The Defense Department Get Around To Generex? 3:22 a.m. Oct. 1, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:15 a.m. Sept. 29, 2014 - InvestorPlace.com
MannKind and Sanofi Complete Afrezza Collaboration Deal - Analyst Blog 4:45 p.m. Sept. 26, 2014 - Zacks.com
Sanofi Vs. MannKind - Afrezza Is Better For Sanofi 12:56 p.m. Sept. 26, 2014 - Seeking Alpha
NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results 11:09 a.m. Sept. 25, 2014 - benzinga.com
Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss 10:12 a.m. Sept. 25, 2014 - benzinga.com
Short Sellers Make Moves in Key Biotech Stocks 9:54 a.m. Sept. 25, 2014 - 247WallSt.com
Hottest Healthcare Stocks Now – MNKD PTCT VRX CLDX 8:00 a.m. Sept. 25, 2014 - InvestorPlace.com
Cramer's Mad Money - 2 Stocks To Buy Starting With 'A' (9/23/14) 5:49 a.m. Sept. 24, 2014 - Seeking Alpha
5 Stocks With Ugly Sales Growth — HTS MITT UEC MNKD CTEL 3:45 a.m. Sept. 22, 2014 - InvestorPlace.com
Why You Shouldn't Bet Against MannKind (MNKD) Stock - Tale of the Tape 8:39 a.m. Sept. 18, 2014 - Zacks.com
MannKind: Seeing The Forest Through The Trees 6:37 p.m. Sept. 16, 2014 - Seeking Alpha
Al Mann Trounces The Afrezza Bear Case In Interview With Noted Diabetes Educator 6:01 p.m. Sept. 16, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:45 a.m. Sept. 15, 2014 - InvestorPlace.com
New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin 2:15 p.m. Sept. 14, 2014 - Seeking Alpha
MannKind In Turmoil: Is It Time To Buy Or Sell? 7:52 a.m. Sept. 12, 2014 - Seeking Alpha
MannKind: Nothing But Good News, Trading Volume Drops, Short Interest Remains Sky High 3:30 p.m. Sept. 11, 2014 - Seeking Alpha
Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver 9:31 a.m. Oct. 3, 2014 - PR Newswire - PRF
Insider Trading Alerts for Comcast, RF Micro Devices, Broadcom, GoPro, MannKind, and Yahoo 8:55 a.m. Oct. 3, 2014 - PR Newswire - PRF
MannKind Announces Receipt of $150 Million Licensing Upfront Payment 7:30 p.m. Sept. 29, 2014 - GlobeNewswire
Insider Trading Reports for Apple, Cisco, Yahoo, Tesla, MannKind, and Bank of America 8:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Insider Trading Alerts for Facebook, Apple, Cisco, Verizon, MannKind, and Tesla Motors 8:55 a.m. Sept. 26, 2014 - PR Newswire - PRF
MannKind Announces Closing of Global Licensing Agreement With Sanofi 5:01 p.m. Sept. 24, 2014 - GlobeNewswire
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference 5:01 p.m. Sept. 2, 2014 - GlobeNewswire
Critical Alerts For MannKind, Best Buy, Splunk, Rite Aid and Allscripts Released By InvestorsObserver 9:31 a.m. Aug. 28, 2014 - PR Newswire - PRF
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver 9:31 a.m. Aug. 12, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Second Quarter Financial Results 9:01 a.m. Aug. 11, 2014 - GlobeNewswire
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin 1:13 a.m. Aug. 11, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
MannKind Receives $150 Million Upfront Payment from Sanofi - Analyst Blog 5:10 p.m. Oct. 3, 2014 - Zacks.com
MannKind Reality Check 10:23 a.m. Oct. 2, 2014 - Seeking Alpha
Why MannKind Stock (MNKD) Is a Screaming Buy 10:16 a.m. Oct. 2, 2014 - InvestorPlace.com
With Ebola Looming, When Will The Defense Department Get Around To Generex? 3:22 a.m. Oct. 1, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:15 a.m. Sept. 29, 2014 - InvestorPlace.com
MannKind and Sanofi Complete Afrezza Collaboration Deal - Analyst Blog 4:45 p.m. Sept. 26, 2014 - Zacks.com
Sanofi Vs. MannKind - Afrezza Is Better For Sanofi 12:56 p.m. Sept. 26, 2014 - Seeking Alpha
NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results 11:09 a.m. Sept. 25, 2014 - benzinga.com
Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss 10:12 a.m. Sept. 25, 2014 - benzinga.com
Short Sellers Make Moves in Key Biotech Stocks 9:54 a.m. Sept. 25, 2014 - 247WallSt.com
Hottest Healthcare Stocks Now – MNKD PTCT VRX CLDX 8:00 a.m. Sept. 25, 2014 - InvestorPlace.com
Cramer's Mad Money - 2 Stocks To Buy Starting With 'A' (9/23/14) 5:49 a.m. Sept. 24, 2014 - Seeking Alpha
5 Stocks With Ugly Sales Growth — HTS MITT UEC MNKD CTEL 3:45 a.m. Sept. 22, 2014 - InvestorPlace.com
Why You Shouldn't Bet Against MannKind (MNKD) Stock - Tale of the Tape 8:39 a.m. Sept. 18, 2014 - Zacks.com
MannKind: Seeing The Forest Through The Trees 6:37 p.m. Sept. 16, 2014 - Seeking Alpha
Al Mann Trounces The Afrezza Bear Case In Interview With Noted Diabetes Educator 6:01 p.m. Sept. 16, 2014 - Seeking Alpha
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:45 a.m. Sept. 15, 2014 - InvestorPlace.com
New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin 2:15 p.m. Sept. 14, 2014 - Seeking Alpha
MannKind In Turmoil: Is It Time To Buy Or Sell? 7:52 a.m. Sept. 12, 2014 - Seeking Alpha
MannKind: Nothing But Good News, Trading Volume Drops, Short Interest Remains Sky High 3:30 p.m. Sept. 11, 2014 - Seeking Alpha
Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver 9:31 a.m. Oct. 3, 2014 - PR Newswire - PRF
Insider Trading Alerts for Comcast, RF Micro Devices, Broadcom, GoPro, MannKind, and Yahoo 8:55 a.m. Oct. 3, 2014 - PR Newswire - PRF
MannKind Announces Receipt of $150 Million Licensing Upfront Payment 7:30 p.m. Sept. 29, 2014 - GlobeNewswire
Insider Trading Reports for Apple, Cisco, Yahoo, Tesla, MannKind, and Bank of America 8:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Insider Trading Alerts for Facebook, Apple, Cisco, Verizon, MannKind, and Tesla Motors 8:55 a.m. Sept. 26, 2014 - PR Newswire - PRF
MannKind Announces Closing of Global Licensing Agreement With Sanofi 5:01 p.m. Sept. 24, 2014 - GlobeNewswire
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference 5:01 p.m. Sept. 2, 2014 - GlobeNewswire
Critical Alerts For MannKind, Best Buy, Splunk, Rite Aid and Allscripts Released By InvestorsObserver 9:31 a.m. Aug. 28, 2014 - PR Newswire - PRF
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver 9:31 a.m. Aug. 12, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Second Quarter Financial Results 9:01 a.m. Aug. 11, 2014 - GlobeNewswire
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin 1:13 a.m. Aug. 11, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼